A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Clinical trial NCT07570862 · RECRUITING

Trial details

NCT number: NCT07570862
Sponsor: Fate Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis Systemic Lupus Erythematosus SLE - Systemic Lupus Erythematosus Lupus Nephritis - WHO Class III Lupus Nephritis - WHO Class IV

Start date: 2026-07-27
Primary completion: 2029-07-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.